Search

Author/Creator González, Luis Javier

1. A COVID-19 vaccine candidate composed of the SARS-CoV-2 RBD dimer and Neisseria meningitidis outer membrane vesicles. Issue 2 (11th January 2022)

Authors:
Santana-Mederos, Darielys; Perez-Nicado, Rocmira; Climent, Yanet; Rodriguez, Laura; Ramirez, Belinda Sanchez; Perez-Rodriguez, Sonia; Rodriguez, Meybi; Labrada, Claudia; Hernandez, Tays; Diaz, Marianniz; Orosa, Ivette; Ramirez, Ubel; Oliva, Reynaldo; Garrido, Raine; Cardoso, Felix; Landys, Mario;...
Journal:
RSC chemical biology
Issue:
Volume 3:Issue 2(2022)
Page Start:
242
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. A deeper mining on the protein composition of VA-MENGOC-BC®: An OMV-based vaccine against N. meningitidis serogroup B and C. Issue 11 (2nd November 2017)

Authors:
Masforrol, Yordanka; Gil, Jeovanis; García, Darien; Noda, Jesús; Ramos, Yassel; Betancourt, Lázaro; Guirola, Osmany; González, Sonia; Acevedo, Boris; Besada, Vladimir; Reyes, Osvaldo; González, Luis Javier
Journal:
Human vaccines & immunotherapeutics
Issue:
Volume 13:Issue 11(2017)
Page Start:
2548
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Characterization of low‐abundance species in the active pharmaceutical ingredient of CIGB‐300: A clinical‐grade anticancer synthetic peptide. (20th April 2018)

Authors:
Garay, Hilda; Espinosa, Luis Ariel; Perera, Yasser; Sánchez, Aniel; Diago, David; Perea, Silvio E.; Besada, Vladimir; Reyes, Osvaldo; González, Luis Javier
Journal:
Journal of peptide science
Issue:
Volume 24:Number 6(2018)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗